The University of Manitoba campuses are located on original lands of Anishinaabeg, Ininew, Anisininew, Dakota and Dene peoples, and on the National Homeland of the Red River Métis. More
University of Manitoba
Winnipeg, Manitoba Canada, R3T 2N2
Max Rady College of Medicine
Internal Medicine, Section of Medical Oncology and Hematology
L101-13, 409 Tache Avenue
Winnipeg, MB R2H 2A6
Phone: 204-235-3394
Fax: 204-237-6048
saroj.niraula@umanitoba.ca or sniraula@cancercare.mb.ca
Dr. Saroj Niraula's research encompasses four main themes: cancer drug regulation, toxicity assessment of new anticancer drugs, global oncology, and real-world outcomes. He actively participates in approving new cancer drugs in Manitoba and has published extensively in respected medical journals such as the Journal of Clinical Oncology and the Journal of the American Medical Association.
His research interests include cancer policy, clinical trial methods, drug regulations, and global oncology. Dr. Niraula holds positions at the Max Rady College of Medicine and the Research Institute of Oncology and Hematology (RIOH), CancerCare Manitoba. He is also affiliated with the Specialized Services for Children and Youth (SSCY) Research and Evaluation Committee, the SPOR Evidence Alliance Research Network, and the International Research Network on Transitions to Adulthood from Care (INTRAC).
Dr. Niraula's research interests include:
Max Rady College of Medicine, Internal Medicine, Section of Medical Oncology and Hematology
Research Institute of Oncology and Hematology (RIOH), CancerCare Manitoba
Specialized Services for Children and Youth (SSCY) Research and Evaluation Committee
SPOR Evidence Alliance Research Network
International Research Network on Transitions to Adulthood from Care (INTRAC)
Dr. Saroj Niraula is an associate professor in internal medicine at the Max Rady College of Medicine. He serves as a medical oncologist at CancerCare Manitoba and is a scientist at the Research Institute of Oncology and Hematology, CancerCare Manitoba. Dr. Niraula's clinical focus lies in treating solid organ malignancies, with an emphasis on breast cancer treatment. Additionally, he chairs the breast cancer program at CancerCare Manitoba.
His research interests encompass cancer policy, clinical trial methods, global oncology, and cancer drug regulation. Dr. Niraula is involved in approving new cancer drugs in Manitoba and has authored numerous articles in esteemed medical journals like the Journal of Clinical Oncology and the Journal of the American Medical Association.
Beyond his academic pursuits, Dr. Niraula is dedicated to training the next generation of Canadian oncologists. He actively mentors cancer doctors from low- and middle-income countries and participates in initiatives aimed at enhancing global cancer outcomes.
Internal Medicine
Room GC430, Health Sciences Centre
820 Sherbrook Street
University of Manitoba
Winnipeg, MB R3A 1R9 Canada
